Home - Products - JAK/STAT Signaling - STAT - Totrombopag

Totrombopag

CAS No. 376592-42-6

Totrombopag( —— )

Catalog No. M34722 CAS No. 376592-42-6

Totrombopag (SB559448) is a candidate compound for action on RSV polymerase.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
2MG	532	Get Quote
5MG	787	Get Quote
10MG	1074	Get Quote
25MG	1463	Get Quote
50MG	1822	Get Quote
100MG	2250	Get Quote
500MG	4410	Get Quote
1G	Get Quote	Get Quote

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

Totrombopag
Note

Research use only, not for human use.
Brief Description

Totrombopag (SB559448) is a candidate compound for action on RSV polymerase.
Description

Totrombopag (SB559448) is a candidate compound for action on RSV polymerase.
In Vitro

——
In Vivo

——
Synonyms

——
Pathway

JAK/STAT Signaling
Target

STAT
Recptor

RSV
Research Area

——
Indication

——

Chemical Information

CAS Number

376592-42-6
Formula Weight

466.49
Molecular Formula

C25H22N8O2
Purity

>98% (HPLC)
Solubility

——
SMILES

O=C1N(N=C(C)C1N=NC2=C(O)C(=CC=C2)C3=CC(=CC=C3)C=4NN=NN4)C5=CC(C)=C(C)C=C5
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

STAT5b inhibitor 7

STAT5b inhibitor 7 (Capstafin prodrug) is the pivaloyloxymethyl ester prodrug of Capstafin.
LLL-12

A nonpeptide, cell-permeable STAT3 inhibitor that binds directly to the pTyr705 binding site of the STAT3 monomer.
MMPP

MMPP is a novel VEGFR2 inhibitor with anti-inflammatory and potential anticancer activity, inhibits STAT3, inhibits angiogenesis via VEGFR2/AKT/ERK/NF-kappaB pathway, and can be used to alleviate myocardial injury.

Sign In Join Free